Skip to main content
logo
Gyre Therapeutics, Inc. (GYRE)
NASDAQ: GYRE · Real-Time Price · USD
6.29
+0.06 (0.96%)
At close: Jun 26, 2026, 4:00 PM EDT
6.34
+0.05 (0.79%)
After-hours: Jun 26, 2026, 5:08 PM EDT

Revenue by Segment

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22
Gyre Pharmaceuticals
116.59M105.76M113.45M102.29M
Gyre Pharmaceuticals Growth
10.24%-6.78%10.91%-
Total
116.59M105.76M113.45M102.29M
Total Growth
10.24%-6.78%10.91%-

Revenue by Geography

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22
Mainland China
116.59M105.76M113.45M102.29M
Mainland China Growth
10.24%-6.78%10.91%-
Total
116.59M105.76M113.45M102.29M
Total Growth
10.24%-6.78%10.91%-